GB2105189B - Inhalation drugs - Google Patents

Inhalation drugs

Info

Publication number
GB2105189B
GB2105189B GB08220158A GB8220158A GB2105189B GB 2105189 B GB2105189 B GB 2105189B GB 08220158 A GB08220158 A GB 08220158A GB 8220158 A GB8220158 A GB 8220158A GB 2105189 B GB2105189 B GB 2105189B
Authority
GB
United Kingdom
Prior art keywords
inhalation drugs
inhalation
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08220158A
Other versions
GB2105189A (en
Inventor
Terence David Boardman
Raymond Brian Forrester
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB8122846 priority Critical
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB08220158A priority patent/GB2105189B/en
Publication of GB2105189A publication Critical patent/GB2105189A/en
Application granted granted Critical
Publication of GB2105189B publication Critical patent/GB2105189B/en
Application status is Expired legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
GB08220158A 1981-07-24 1982-07-12 Inhalation drugs Expired GB2105189B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB8122846 1981-07-24
GB08220158A GB2105189B (en) 1981-07-24 1982-07-12 Inhalation drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08220158A GB2105189B (en) 1981-07-24 1982-07-12 Inhalation drugs

Publications (2)

Publication Number Publication Date
GB2105189A GB2105189A (en) 1983-03-23
GB2105189B true GB2105189B (en) 1985-03-20

Family

ID=26280237

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08220158A Expired GB2105189B (en) 1981-07-24 1982-07-12 Inhalation drugs

Country Status (1)

Country Link
GB (1) GB2105189B (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5997848A (en) 1994-03-07 1999-12-07 Inhale Therapeutic Systems Methods and compositions for pulmonary delivery of insulin
US6143277A (en) 1995-04-14 2000-11-07 Glaxo Wellcome Inc. Metered dose inhaler for salmeterol
US6149892A (en) 1995-04-14 2000-11-21 Glaxowellcome, Inc. Metered dose inhaler for beclomethasone dipropionate
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US7744925B2 (en) 1994-12-02 2010-06-29 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7967221B2 (en) 2002-12-30 2011-06-28 Novartis Ag Prefilming atomizer
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8173168B2 (en) 1994-03-07 2012-05-08 Novartis Pharma Ag Dispersible macromolecule compositions and methods for their preparation and use
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US8273330B2 (en) 2002-04-25 2012-09-25 Nektar Therapeutics Particulate materials
US8337895B2 (en) 2000-06-30 2012-12-25 Novartis Ag Spray drying process control of drying kinetics
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8524279B2 (en) 2001-11-01 2013-09-03 Novartis Ag Spray drying methods and related compositions
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US8802149B2 (en) 1996-12-31 2014-08-12 Novartis Pharma Ag Systems and processes for spray drying hydrophobic and hydrophilic components
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US9120031B2 (en) 2000-11-09 2015-09-01 Nektar Therapeutics Compositions of particulate coformulation

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8911259D0 (en) * 1989-05-17 1989-07-05 Fisons Plc Inhalation medicament
DE69636757T2 (en) 1995-04-14 2007-10-11 Smithkline Beecham Corp. Metered dose inhaler for Fluticasonepropionat
HU219900B (en) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. metered dose inhaler Found
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
EP2425819A1 (en) 2007-02-11 2012-03-07 MAP Pharmaceuticals Inc Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
US9808030B2 (en) 2011-02-11 2017-11-07 Grain Processing Corporation Salt composition

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582728B1 (en) 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6797258B2 (en) 1992-07-08 2004-09-28 Nektar Therapeutics Compositions and methods for the pulmonary delivery of aerosolized macromolecules
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
US6737045B2 (en) 1994-03-07 2004-05-18 Nektar Therapeutics Methods and compositions for the pulmonary delivery insulin
US6685967B1 (en) 1994-03-07 2004-02-03 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
US8173168B2 (en) 1994-03-07 2012-05-08 Novartis Pharma Ag Dispersible macromolecule compositions and methods for their preparation and use
US5997848A (en) 1994-03-07 1999-12-07 Inhale Therapeutic Systems Methods and compositions for pulmonary delivery of insulin
US7785631B2 (en) 1994-12-02 2010-08-31 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7744925B2 (en) 1994-12-02 2010-06-29 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US7780991B2 (en) 1994-12-02 2010-08-24 Quadrant Drug Delivery Limited Solid dose delivery vehicle and methods of making same
US6511653B1 (en) 1995-04-14 2003-01-28 Smithkline Beecham Corp. Metered dose inhaler for beclomethasone dipropionate
US6143277A (en) 1995-04-14 2000-11-07 Glaxo Wellcome Inc. Metered dose inhaler for salmeterol
US6511652B1 (en) 1995-04-14 2003-01-28 Smithkline Beecham Corp. Metered dose inhaler for beclomethasone dipropionate
US6149892A (en) 1995-04-14 2000-11-21 Glaxowellcome, Inc. Metered dose inhaler for beclomethasone dipropionate
US8802149B2 (en) 1996-12-31 2014-08-12 Novartis Pharma Ag Systems and processes for spray drying hydrophobic and hydrophilic components
US8246934B2 (en) 1997-09-29 2012-08-21 Novartis Ag Respiratory dispersion for metered dose inhalers comprising perforated microstructures
US9554993B2 (en) 1997-09-29 2017-01-31 Novartis Ag Pulmonary delivery particles comprising an active agent
US8877162B2 (en) 2000-05-10 2014-11-04 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery
US9439862B2 (en) 2000-05-10 2016-09-13 Novartis Ag Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US8709484B2 (en) 2000-05-10 2014-04-29 Novartis Ag Phospholipid-based powders for drug delivery
US8337895B2 (en) 2000-06-30 2012-12-25 Novartis Ag Spray drying process control of drying kinetics
US9120031B2 (en) 2000-11-09 2015-09-01 Nektar Therapeutics Compositions of particulate coformulation
US8524279B2 (en) 2001-11-01 2013-09-03 Novartis Ag Spray drying methods and related compositions
US8936813B2 (en) 2001-11-01 2015-01-20 Novartis Ag Spray drying methods and related compositions
US9421166B2 (en) 2001-12-19 2016-08-23 Novartis Ag Pulmonary delivery of aminoglycoside
US8715623B2 (en) 2001-12-19 2014-05-06 Novartis Ag Pulmonary delivery of aminoglycoside
US8273330B2 (en) 2002-04-25 2012-09-25 Nektar Therapeutics Particulate materials
US7967221B2 (en) 2002-12-30 2011-06-28 Novartis Ag Prefilming atomizer
US8616464B2 (en) 2002-12-30 2013-12-31 Novartis Ag Prefilming atomizer
US8586005B2 (en) 2004-06-04 2013-11-19 Acusphere, Inc. Ultrasound contrast agent dosage formulation
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation

Also Published As

Publication number Publication date
GB2105189A (en) 1983-03-23

Similar Documents

Publication Publication Date Title
DE3473834D1 (en) Inhalation device
DE3466478D1 (en) Inhalation device
DE3278102D1 (en) Catheter introduction set
GB2176404B (en) Respirator
GB2098602B (en) Therapeutic agents
DE3263209D1 (en) Drug administration device
GB2116725B (en) Respiration monitor
DE3262782D1 (en) Aerosol inhalation device
GB2156220B (en) Improved cannula
GB2097680B (en) Medicament applicator
DE3273153D1 (en) Pharmaceutical mixture
AU545918B2 (en) Inhalator
DE3175083D1 (en) Pharmaceutical compounds, their preparation and use
DE3273948D1 (en) Pharmaceutical preparations
GB2096911B (en) Atomiser
AU559297B2 (en) Dosage inhalator
AU560654B2 (en) Dosage inhalator
DE3573729D1 (en) Medicament inhalation device
GB2101500B (en) Ultrasonic inhaler
JPS565161A (en) Inhaler
JPS57192566A (en) Cathetel set
ZA8601081B (en) Inhalation apparatus
GB8523795D0 (en) Respirator
IE820308L (en) Pharmaceutical composition
EP0128831A3 (en) Drug administration

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940712